The effect of MX-1 and FOY on survival of discordant cardiac xenograft.
Kaji
H
H
First Department of Surgery, Faculty of Medicine, Kyoto University, Japan.
Platt
J L
JL
Inoue
K
K
Setoyama
H
H
Imamura
M
M
D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology*; D003169:Complement Inactivator Proteins / Q000494:pharmacology*; D003402:Creatine Kinase / Q000097:blood; D016670:Gabexate / Q000494:pharmacology*; D006085:Graft Survival / Q000187:drug effects*; D006168:Guinea Pigs; D016027:Heart Transplantation / Q000276:immunology* / Q000502:physiology; D007165:Immunosuppression Therapy; D007527:Isoenzymes; D051381:Rats; D011917:Rats, Inbred Lew; D012717:Sesquiterpenes / Q000494:pharmacology*; D014183:Transplantation, Heterologous / Q000276:immunology* / Q000502:physiology
D000925:Anticoagulants; D003169:Complement Inactivator Proteins; D007527:Isoenzymes; D012717:Sesquiterpenes; D016670:Gabexate; C038797:K 76 carboxylic acid; D003402:Creatine Kinase